Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 4, p. s220, 2023. DOI: 10.25251/skin.7.supp.220. Disponível em: https://skin.dermsquared.com/skin/article/view/2195. Acesso em: 18 apr. 2025.